Evidence map›Paper›PMID 39229023›Full record

ArticlebioRxiv : the preprint server for biology2025

Sensitive and modular amplicon sequencing of

Andrés Aranda-Díaz, Eric Neubauer Vickers, Kathryn Murie, Brian Palmer, Nicholas Hathaway, Inna Gerlovina, Simone Boene, Manuel Garcia-Ulloa, Pau Cisteró, Thomas Katairo and 24 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors.

Andrés Aranda-DíazEPPIcenter Research Program, Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, California, USA.ORCID 0000-0002-0566-4901
Eric Neubauer VickersEPPIcenter Research Program, Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, California, USA.
Kathryn MurieEPPIcenter Research Program, Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, California, USA.
Brian PalmerEPPIcenter Research Program, Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, California, USA.
Nicholas HathawayEPPIcenter Research Program, Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, California, USA.
Inna GerlovinaEPPIcenter Research Program, Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, California, USA.
Simone BoeneCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Manuel Garcia-UlloaISGlobal, Barcelona, Spain.
Pau CisteróISGlobal, Barcelona, Spain.
Thomas KatairoInfectious Diseases Research Collaboration, Kampala, Uganda.
Francis Ddumba SemakubaInfectious Diseases Research Collaboration, Kampala, Uganda.
Bienvenu NsengimaanaInfectious Diseases Research Collaboration, Kampala, Uganda.
Hazel GwarindaLaboratory for Antimalarial Resistance Monitoring and Malaria Operational Research (ARMMOR), Centre of Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases, Johannesburg, South Africa.
Carla García-FernándezISGlobal, Barcelona, Spain.
William LouieEPPIcenter Research Program, Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, California, USA.
Endashaw EsayasArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Clemente Da SilvaCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Debayan DattaISGlobal, Barcelona, Spain.
Shahiid KiyagaInfectious Diseases Research Collaboration, Kampala, Uganda.
Innocent WiringilimaanaInfectious Diseases Research Collaboration, Kampala, Uganda.
Sindew Mekasha FekeleEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Adam BennettPATH, Seattle, Washington, USA.
Jennifer L SmithMalaria Elimination Initiative, Global Health Group, University of California, San Francisco, United States of America.
Endalamaw GadisaArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Jonathan B ParrDivision of Infectious Diseases, University of North Carolina at Chapel Hill, North Carolina, USA.
Melissa ConradDivision of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, California, USA.ORCID 0000-0002-9984-8030
Jaishree RamanLaboratory for Antimalarial Resistance Monitoring and Malaria Operational Research (ARMMOR), Centre of Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases, Johannesburg, South Africa.
Stephen TukwasibweInfectious Diseases Research Collaboration, Kampala, Uganda.
Isaac SsewanyanaInfectious Diseases Research Collaboration, Kampala, Uganda.
Eduard Rovira-VallbonaCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Cristina M TatoChan Zuckerberg Biohub, San Francisco, California, USA.
Jessica BriggsEPPIcenter Research Program, Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, California, USA.
Alfredo MayorCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.ORCID 0000-0003-3890-2897
Bryan GreenhouseEPPIcenter Research Program, Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, California, USA.

Funding

Mentoring translational scientists in international infectious disease researchK24AI144048 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Bryan R Greenhouse · 2019 to 2026
$1.6M
Improving the accuracy of malaria surveillance with serology and parasite genetic dataK23AI166009 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jessica Briggs · 2022 to 2026
$955k
Genetics Modifiers of Anthrax Lethal Toxin Induced PathophysiologyR01AI077791 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BRADLEY, KENNETH ALAN · 2009 to 2010
$765k
Genetic and social network analysis to target interventions for malaria eliminationK01AI153555 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SMITH, JENNIFER LINNEA · 2020 to 2024
$725k
Translational Studies of Plasmodium Falciparum Infection DynamicsK23AI076614 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GREENHOUSE, BRYAN R · 2008 to 2012
$609k
Gates Foundation INV-003212Gates Foundation INV-019032Gates Foundation INV-024346Gates Foundation INV-031512Gates Foundation INV-037316NIAID NIH HHS K01 AI153555NIAID NIH HHS K23 AI166009NIAID NIH HHS K24 AI144048NIAID NIH HHS R01 AI077791
6 · The paper itself

Abstract

Background: Targeted amplicon sequencing is a powerful and efficient tool for interrogating the Methods: We developed, characterized, and implemented MAD Results: MAD Conclusions: The successful implementation of MAD

Indexed as

antimalarial resistancecomplexity of infectioncsphrp2 deletionidentity-by-descentmalariaMalariamicrohaplotypePlasmodium falciparumTargeted amplicon sequencing

Identifiers

PMID39229023
PMCPMC11370457

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.